Prudential Financial Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.21 - $0.43 $2,520 - $5,160	12,000 New	12,000 $2,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $2,652 - $19,448	2,600 Added 1.31%	200,395 $0
Q3 2022 Nov 04, 2022	BUY	$6.04 - $9.66 $824,097 - $1.32 Million	136,440 Added 222.38%	197,795 $1.49 Million
Q2 2022 Aug 15, 2022	BUY	$4.99 - $8.96 $226,266 - $406,282	45,344 Added 283.21%	61,355 $387,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $34,928 - $54,498	4,388 Added 37.75%	16,011 $130,000
Q1 2020 May 12, 2020	BUY	$4.91 - $14.7 $57,068 - $170,858	11,623 New	11,623 $79,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.